Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Proc Natl Acad Sci U S A ; 109(43): E2939-48, 2012 Oct 23.
Article in English | MEDLINE | ID: mdl-23019585

ABSTRACT

Chemoresistance to platinum therapy is a major obstacle that needs to be overcome in the treatment of ovarian cancer patients. The high rates and patterns of therapeutic failure seen in patients are consistent with a steady accumulation of drug-resistant cancer stem cells (CSCs). This study demonstrates that the Notch signaling pathway and Notch3 in particular are critical for the regulation of CSCs and tumor resistance to platinum. We show that Notch3 overexpression in tumor cells results in expansion of CSCs and increased platinum chemoresistance. In contrast, γ-secretase inhibitor (GSI), a Notch pathway inhibitor, depletes CSCs and increases tumor sensitivity to platinum. Similarly, a Notch3 siRNA knockdown increases the response to platinum therapy, further demonstrating that modulation of tumor chemosensitivity by GSI is Notch specific. Most importantly, the cisplatin/GSI combination is the only treatment that effectively eliminates both CSCs and the bulk of tumor cells, indicating that a dual combination targeting both populations is needed for tumor eradication. In addition, we found that the cisplatin/GSI combination therapy has a synergistic cytotoxic effect in Notch-dependent tumor cells by enhancing the DNA-damage response, G(2)/M cell-cycle arrest, and apoptosis. Based on these results, we conclude that targeting the Notch pathway could significantly increase tumor sensitivity to platinum therapy. Our study suggests important clinical applications for targeting Notch as part of novel treatment strategies upon diagnosis of ovarian cancer and at recurrence. Both platinum-resistant and platinum-sensitive relapses may benefit from such an approach as clinical data suggest that all relapses after platinum therapy are increasingly platinum resistant.


Subject(s)
Antineoplastic Agents/therapeutic use , Cisplatin/therapeutic use , Neoplastic Stem Cells/pathology , Ovarian Neoplasms/pathology , Receptors, Notch/metabolism , Animals , Cell Cycle , Cell Death , DNA Damage , Drug Resistance, Neoplasm , Female , Humans , Mice , Ovarian Neoplasms/drug therapy , Receptor, Notch3 , Xenograft Model Antitumor Assays
2.
Dev Biol ; 304(2): 771-85, 2007 Apr 15.
Article in English | MEDLINE | ID: mdl-17336958

ABSTRACT

longitudinals-lacking (lola) was identified in Drosophila as a gene encoding several alternatively spliced transcription factors involved in axon guidance. Here we report that lola also plays a critical role in programmed cell death in the ovary. lola mutant germline clones show a high percentage of egg chambers with nurse cell nuclei persisting past stage 13, indicating a block in developmental nurse cell death. Mutants also show a disruption in the induced programmed cell death that occurs during mid-oogenesis in response to starvation. Further characterization revealed that lola germline clones exhibit abnormal nuclear organization which becomes increasingly severe with age. Chromatin appears diffuse and fails to condense properly or undergo DNA fragmentation in dying nurse cells. Masses of nuclear material accumulate in the ovaries of older flies containing lola germline clones. We propose that lola is necessary for complete chromatin condensation which occurs during programmed cell death in the ovary. Alleles differed in the strength of their phenotypes but interestingly, the severity of their ovarian phenotypes was independent of the strength of their neuronal phenotypes, suggesting a differential requirement for individual lola isoforms in the ovary and nervous system.


Subject(s)
Apoptosis , Axons/physiology , Drosophila Proteins/metabolism , Drosophila/cytology , Transcription Factors/metabolism , Animals , Cell Differentiation , Cell Nucleus/metabolism , Cell Nucleus/ultrastructure , Chromatin/physiology , Drosophila Proteins/genetics , Female , Mutation , Oogenesis , Ovary/cytology , Protein Isoforms/genetics , Protein Isoforms/metabolism , Transcription Factors/genetics
3.
Dev Biol ; 275(1): 82-92, 2004 Nov 01.
Article in English | MEDLINE | ID: mdl-15464574

ABSTRACT

Programmed cell death is a critical process for the patterning and sculpting of organs during development. The Drosophila arista, a feather-like structure at the tip of the antenna, is composed of a central core and several lateral branches. A homozygous viable mutation in the thread gene, which encodes an inhibitor of apoptosis protein, produces a branchless arista. We have found that mutations in the proapoptotic gene hid lead to numerous extra branches, suggesting that the level of cell death determines the number of branches in the arista. Consistent with this idea, we have found that thread mutants show excessive cell death restricted to the antennal imaginal disc during the middle third instar larval stage. These findings point to a narrow window of development in which regulation of programmed cell death is essential to the proper formation of the arista.


Subject(s)
Apoptosis/physiology , Drosophila/physiology , Animals , Body Patterning/physiology , Caspase 3 , Caspases/metabolism , Drosophila/enzymology , Drosophila/growth & development , Drosophila Proteins/genetics , Drosophila Proteins/metabolism , Larva/growth & development , Larva/physiology , Mutation , Neuropeptides/genetics , Neuropeptides/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...